160 related articles for article (PubMed ID: 28554575)
21. Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression.
Tang G; Liu D; Xiao G; Liu Q; Yuan J
Oncotarget; 2016 Dec; 7(49):81757-81767. PubMed ID: 27835585
[TBL] [Abstract][Full Text] [Related]
22. Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.
Ashford AL; Dunkley TP; Cockerill M; Rowlinson RA; Baak LM; Gallo R; Balmanno K; Goodwin LM; Ward RA; Lochhead PA; Guichard S; Hudson K; Cook SJ
Cell Mol Life Sci; 2016 Feb; 73(4):883-900. PubMed ID: 26346493
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication.
Hamilton ST; Hutterer C; Egilmezer E; Steingruber M; Milbradt J; Marschall M; Rawlinson WD
Placenta; 2018 Dec; 72-73():10-19. PubMed ID: 30501876
[TBL] [Abstract][Full Text] [Related]
24. Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence.
Zhou N; Yuan S; Wang R; Zhang W; Chen JJ
Oncotarget; 2015 Oct; 6(31):30745-61. PubMed ID: 26307683
[TBL] [Abstract][Full Text] [Related]
25. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
26. Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice.
Masuda T; Itoh K; Higashitsuji H; Higashitsuji H; Nakazawa N; Sakurai T; Liu Y; Tokuchi H; Fujita T; Zhao Y; Nishiyama H; Tanaka T; Fukumoto M; Ikawa M; Okabe M; Fujita J
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10885-90. PubMed ID: 22711815
[TBL] [Abstract][Full Text] [Related]
27. Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
Hu J; Deng H; Friedman EA
Int J Cancer; 2013 May; 132(10):2258-69. PubMed ID: 23114871
[TBL] [Abstract][Full Text] [Related]
28. The Clinical Implications of RSK1-3 in Human Breast Cancer.
Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
[TBL] [Abstract][Full Text] [Related]
29. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
30. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
[TBL] [Abstract][Full Text] [Related]
31. Proliferation (Ki-67 and phosphohistone H3) and oncotype DX recurrence score in estrogen receptor-positive breast cancer.
Williams DJ; Cohen C; Darrow M; Page AJ; Chastain B; Adams AL
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):431-6. PubMed ID: 21297447
[TBL] [Abstract][Full Text] [Related]
32. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
33. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
[TBL] [Abstract][Full Text] [Related]
34. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
35. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
36. The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
Song LN; Silva J; Koller A; Rosenthal A; Chen EI; Gelmann EP
Mol Cancer Res; 2015 May; 13(5):913-22. PubMed ID: 25777618
[TBL] [Abstract][Full Text] [Related]
37. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.
Wang S; Li W; Liu N; Zhang F; Liu H; Liu F; Liu J; Zhang T; Niu Y
J Cell Biochem; 2012 Jun; 113(6):1904-14. PubMed ID: 22234886
[TBL] [Abstract][Full Text] [Related]
38. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
40. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
